Atlas Trials

1st-line Activity of Dovitinib and Correlation With Genetic Changes in RCC

Clinical trial NCT01791387 · UNKNOWN

Trial details

NCT number
NCT01791387
Sponsor
Auckland District Health Board
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Clear Cell Renal Cell Carcinoma
Start date
2012-03-01
Primary completion
2015-06-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.